Post of the day

Jury In Sophos Trial Awards FNJN $15 million

By Lisa Thompson Finjan (NASDAQ:FNJN) won its trial against Sophos yesterday and was awarded $ 15 million for the life of the patents. This was at the high end of the range that an expert witness suggested. The jury decided that Sophos infringed upon all eight patents. It also decided the infringement was not willful…